Vikas Borge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vikas Borge has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bhushan Bhagwantrao Popatkar
Department of Chemistry, University of Mumbai
3 shared publications - Satish B. Manjare
Department of Chemistry, University of Mumbai
3 shared publications - Pragati Kharpade
Department of Chemistry, University of Mumbai
1 shared publication - Pratima Yadav
Department of Chemistry, Institute of Chemical Technology, Mumbai
1 shared publication - Preeti Dwivedi
Department of Chemistry, K.J. Somaiya College, Mumbai
1 shared publication - Ramchandra Thorat
University of Mumbai
1 shared publication
Latest Publications
- 4 January 2026
- Published by ACG Publications in Organic Communications
- Vol. 19 (2)
Studies on development of non-conventional method and various applications of Quinoline Scaffolds
Quinoline is one of the most widely studied scaffold due to its high biological activities like antimalarial, antitubercular, antitumor, anti-inflammatory, antifungal, antiprotozoal, etc. this compound also has corrosion resistant, fluorescent properties, which make it industrially also important. There are various conventional methods to synthesize this scaffold, but these have several drawbacks like harsh conditions, susceptible functional group get affected. These drawbacks can be overcome by the use of green methods. These methods include Tandem/domino methods, cascade synthesis, cyclization/annulation by C-C, C-N bond formation, use of microwave, ultrasonication, ionic liquids, recyclable nano-catalyst, solid phase synthesis, solvent free synthesis, water as solvent, ball milling, use of cheap, easily available metal catalyst etc. Nowadays various naturally occurring biomass as raw material are also utilized as one of the reactant. These green methods reduce hazards to human as well as environment. This review provides an overview of recent discoveries in green synthetic methods of quinoline scaffold, and various applications of quinoline scaffold in medicine and other industrial applications.
- 4 January 2026
- Published by ACG Publications in Organic Communications
- Vol. 19 (2)
Studies on development of non-conventional method and various applications of Quinoline Scaffolds
Quinoline is one of the most widely studied scaffold due to its high biological activities like antimalarial, antitubercular, antitumor, anti-inflammatory, antifungal, antiprotozoal, etc. this compound also has corrosion resistant, fluorescent properties, which make it industrially also important. There are various conventional methods to synthesize this scaffold, but these have several drawbacks like harsh conditions, susceptible functional group get affected. These drawbacks can be overcome by the use of green methods. These methods include Tandem/domino methods, cascade synthesis, cyclization/annulation by C-C, C-N bond formation, use of microwave, ultrasonication, ionic liquids, recyclable nano-catalyst, solid phase synthesis, solvent free synthesis, water as solvent, ball milling, use of cheap, easily available metal catalyst etc. Nowadays various naturally occurring biomass as raw material are also utilized as one of the reactant. These green methods reduce hazards to human as well as environment. This review provides an overview of recent discoveries in green synthetic methods of quinoline scaffold, and various applications of quinoline scaffold in medicine and other industrial applications.
- 23 December 2025
- Published by ACG Publications in Organic Communications
- Vol. 18 (4) , 208-249
An outline of antidiabetic medications and their synthetic pathways
One of the most common chronic illnesses and a major cause of death in recent years is diabetes mellitus (DM). As a result, strategies for identifying, stopping, or delaying this illness and its co-morbidities have long been debated. Patients with diabetes mellitus (DM), especially those with type 2 DM, are now recommended to modify their diet and exercise routines and to gradually go from monotherapy, dual therapy, and multi-agent therapy to insulin delivery as the disease progresses. While there have been advancements, the search for the "ideal" diabetes medication is currently ongoing. There is still much disagreement on the molecular pathways that regulate DM. Since each drug has different risks, drawbacks, side effects, and modes of action, selecting the best course of treatment requires careful consideration. In this article, many classes of anti-diabetic medications were reviewed that are on the market, their uses, and their modes of action. This study will focus especially on the more recent and/or commonly prescribed classes. Since these medications influence the pathways in various cellular systems and organs, encouraging metabolic modifications responsible for either favorable or detrimental consequences, special attention will be paid to how they affect cellular metabolism. It is imperative to thoroughly examine this essential attribute before recommending an antidiabetic. The most common kind of diabetes is type-2, and oral anti-diabetic medications are essential for managing it. Sulfonylureas, thiazolidinediones, meglitinides, sodium glucose co-transporter (SGLT2), a-glucosidase inhibitors, dipeptidyl peptidase-(IV) inhibitors, and biguanides are some of the classes of oral anti-diabetic medications that are marketed today. To avert a possible public emergency, the scientific community has been working hard to create better and more sustainable synthetic methodologies towards these anti-diabetics as the burden of type-2 diabetes continues to rise. The several documented synthetic approaches for anti-diabetic medications in the aforementioned classes are summarized in this article. We hope that this compilation will provide organic and medicinal chemists
- 23 December 2025
- Published by ACG Publications in Organic Communications
- Vol. 18 (4) , 208-249
An outline of antidiabetic medications and their synthetic pathways
One of the most common chronic illnesses and a major cause of death in recent years is diabetes mellitus (DM). As a result, strategies for identifying, stopping, or delaying this illness and its co-morbidities have long been debated. Patients with diabetes mellitus (DM), especially those with type 2 DM, are now recommended to modify their diet and exercise routines and to gradually go from monotherapy, dual therapy, and multi-agent therapy to insulin delivery as the disease progresses. While there have been advancements, the search for the "ideal" diabetes medication is currently ongoing. There is still much disagreement on the molecular pathways that regulate DM. Since each drug has different risks, drawbacks, side effects, and modes of action, selecting the best course of treatment requires careful consideration. In this article, many classes of anti-diabetic medications were reviewed that are on the market, their uses, and their modes of action. This study will focus especially on the more recent and/or commonly prescribed classes. Since these medications influence the pathways in various cellular systems and organs, encouraging metabolic modifications responsible for either favorable or detrimental consequences, special attention will be paid to how they affect cellular metabolism. It is imperative to thoroughly examine this essential attribute before recommending an antidiabetic. The most common kind of diabetes is type-2, and oral anti-diabetic medications are essential for managing it. Sulfonylureas, thiazolidinediones, meglitinides, sodium glucose co-transporter (SGLT2), a-glucosidase inhibitors, dipeptidyl peptidase-(IV) inhibitors, and biguanides are some of the classes of oral anti-diabetic medications that are marketed today. To avert a possible public emergency, the scientific community has been working hard to create better and more sustainable synthetic methodologies towards these anti-diabetics as the burden of type-2 diabetes continues to rise. The several documented synthetic approaches for anti-diabetic medications in the aforementioned classes are summarized in this article. We hope that this compilation will provide organic and medicinal chemists
- 30 June 2025
- Published by ACG Publications in Organic Communications
- Vol. 18 (2) , 38-59
Green methods for the synthesis of chalcones: An overview with appraisal to sustainable development and bioactive compounds
In recent years, there has been a growing interest in developing green and sustainable synthetic strategies for chalcones, aiming to minimize waste, reduce the use of hazardous chemicals, and enhance the overall efficiency of the reactions. This review provides an overview of various green synthesis approaches for chalcones and their derivatives, emphasizing environmentally friendly techniques such as solvent-free reactions, microwave-assisted synthesis, ultrasound-assisted synthesis, and enzyme-catalytic methods. Additionally, the biological activities of chalcones synthesized via green methods are explored, underscoring their potential in drug development and therapeutic applications
- 30 June 2025
- Published by ACG Publications in Organic Communications
- Vol. 18 (2) , 38-59
Green methods for the synthesis of chalcones: An overview with appraisal to sustainable development and bioactive compounds
In recent years, there has been a growing interest in developing green and sustainable synthetic strategies for chalcones, aiming to minimize waste, reduce the use of hazardous chemicals, and enhance the overall efficiency of the reactions. This review provides an overview of various green synthesis approaches for chalcones and their derivatives, emphasizing environmentally friendly techniques such as solvent-free reactions, microwave-assisted synthesis, ultrasound-assisted synthesis, and enzyme-catalytic methods. Additionally, the biological activities of chalcones synthesized via green methods are explored, underscoring their potential in drug development and therapeutic applications